The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASE I F COD FOLL SEQ IMAGE EVENT DT MFR DT FDA DT REPT COD MFR NUM MFR SNDR AGE AGE COD GNDR COD E SUB WT WT COD REPT DT OCCP COD DEATH DT TO MFR CONFID REPORTER COUNTRY
6918679 7476233 F 6918679-9 20100618 20100728 20100811 EXP PHHY2010US40235 NOVARTIS PHARMACEUTICAL CORPORATION 57 YR M Y 89.1 KG 20100811 UNITED STATES

Drug(s) used by person

Event ID DRUG SEQ ROLE COD DRUGNAME VAL VBM ROUTE DOSE VBM DECHAL RECHAL LOT NUM EXP DT NDA NUM
6918679 1014390750 PS EXJADE 1 ORAL 1000 MG, QD 021882
6918679 1014390751 C BLOOD CELLS, PACKED HUMAN 2

Indications of drugs used

Event ID DRUG SEQ INDI PT
6918679 1014390750 MYELODYSPLASTIC SYNDROME

Outcome of event

Event ID OUTC COD
6918679 HO

Reactions reported

Event ID PT
6918679 DIARRHOEA
6918679 FEBRILE NEUTROPENIA
6918679 KNEE OPERATION
6918679 NAUSEA
6918679 VISUAL IMPAIRMENT

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID DRUG SEQ START DT END DT DUR DUR COD
6918679 1014390750 20100611 20100618 8 DAY